It was hypothesized that the feature of transforming the protein signal into an amplifiable signal could overcome the lack of sensitivity associated with the classical ELISA approach and thereby facilitate the use of survivin as a biomarker for bladder cancer detection. This evidence concerns the gene BIRC5 and urinary bladder carcinoma.